Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells.

about

Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells.

Item

http://www.wikidata.org/entity/Q55317203

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Synergistic antitumor activity ...... ive human breast cancer cells.

@en

Synergistic antitumor activity ...... ive human breast cancer cells.

@nl

type

Item

label

Synergistic antitumor activity ...... ive human breast cancer cells.

@en

Synergistic antitumor activity ...... ive human breast cancer cells.

@nl

prefLabel

Synergistic antitumor activity ...... ive human breast cancer cells.

@en

Synergistic antitumor activity ...... ive human breast cancer cells.

@nl

P1476

Synergistic antitumor activity ...... ive human breast cancer cells.

@en

P2093

Ana Laura Martinez

http://www.w3.org/2001/XMLSchema#string

Analía Lourdes Redondo

http://www.w3.org/2001/XMLSchema#string

Angel Matias Sanchez

http://www.w3.org/2001/XMLSchema#string

Fiorella Vanderhoeven

http://www.w3.org/2001/XMLSchema#string

Laura María Vargas-Roig

http://www.w3.org/2001/XMLSchema#string

Marina Inés Flamini

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Cancer statistics, 2014

Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Drug combination studies and their synergy quantification using the Chou-Talalay method

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

ERM proteins: from cellular architecture to cell signaling.

Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.

P304

26527-26542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25480

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29899874

http://www.w3.org/2001/XMLSchema#string

P932

5995169

http://www.w3.org/2001/XMLSchema#string